We are live on ! Find out more
BCYC

Bicycle Therapeutics
BCYC

89 hedge funds and large institutions have $499M invested in Bicycle Therapeutics in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

292% more call options, than puts

Call options by funds: $9.7M | Put options by funds: $2.47M

100% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 17

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

2% more funds holding

Funds holding: 87 → 89 (+2)

0.71% less ownership

Funds ownership: 79.19% → 78.48% (-0.71%)

28% less capital invested

Capital invested by funds: $696M → $499M (-$197M)

75% less funds holding in top 10

Funds holding in top 10: 4 → 1 (-3)

Holders
89
Holders Change
+2
Holders Change %
+2.3%
% of All Funds
1.42%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
18
Increased
34
Reduced
17
Closed
15
Calls
$9.7M
Puts
$2.47M
Net Calls
+$7.22M
Net Calls Change
+$9.98M

Top Buyers

Rank Fund Capital Flow
1
JFG
Jefferies Financial Group
New York
+$48.9M
2
Morgan Stanley
Morgan Stanley
New York
+$19.7M
3
AC
Armistice Capital
New York
+$18.5M
4
PBA
Paradigm Biocapital Advisors
New York
+$14.6M
5
TCM
Tybourne Capital Management
Hong Kong
+$12.6M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$37.3M
2
SC
Samlyn Capital
New York
-$29.2M
3
EAM
Eventide Asset Management
Massachusetts
-$25.3M
4
LGM
Logos Global Management
California
-$17.2M
5
PVI
Pura Vida Investments
New York
-$7.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
PHP
26
Parkman Healthcare Partners
Connecticut
$3.14M +$1.42M +56,467 +62%
Handelsbanken Fonder
27
Handelsbanken Fonder
Sweden
$2.8M – – –
ECM
28
ExodusPoint Capital Management
New York
$2.61M +$449K +17,915 +17%
DCM
29
DAFNA Capital Management
California
$2.6M – – –
HS
30
HighVista Strategies
Massachusetts
$1.97M – – –
TCM
31
Tekla Capital Management
Massachusetts
$1.89M – – –
JP Morgan Chase
32
JP Morgan Chase
New York
$1.85M +$98.6K +3,932 +5%
UOC
33
UBS O'Connor
Illinois
$1.72M +$2.02M +80,719 New
VOYA Investment Management
34
VOYA Investment Management
Georgia
$1.71M +$365K +14,555 +22%
Marshall Wace
35
Marshall Wace
United Kingdom
$1.63M +$1.69M +67,378 +727%
Citadel Advisors
36
Citadel Advisors
Florida
$1.43M +$858K +34,210 +104%
Renaissance Technologies
37
Renaissance Technologies
New York
$1.32M +$1.55M +61,900 New
SSA
38
Schonfeld Strategic Advisors
New York
$1.28M -$493K -19,646 -25%
BG
39
Bellevue Group
Switzerland
$1.13M -$426K -17,000 -24%
JGC
40
J. Goldman & Co
New York
$1.06M +$1.25M +49,944 New
Group One Trading
41
Group One Trading
Illinois
$1.03M +$242K +9,655 +25%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$948K +$189K +7,518 +20%
CSS
43
Cubist Systematic Strategies
Connecticut
$932K +$768K +30,617 +232%
BFM
44
Boothbay Fund Management
New York
$914K +$1.08M +42,979 New
JF
45
Jump Financial
Illinois
$803K +$761K +30,337 +410%
CM
46
Caption Management
Oklahoma
$553K +$652K +26,000 New
Simplex Trading
47
Simplex Trading
Illinois
$550K +$290K +11,554 +81%
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$535K – – –
VIA
49
Vident Investment Advisory
Georgia
$517K +$8.28K +330 +1%
TD Asset Management
50
TD Asset Management
Ontario, Canada
$502K – – –
1
2
3 4 5

BCYC Hedge Fund Activity: Q1 2023 in Review

89 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q1 2023, worth a combined $499M — down 28% from $696M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new BCYC positions and 15 closed out — a net gain of 3 holders — while 34 added to existing stakes and 17 trimmed.

The largest buyer was Jefferies Financial Group, opening a new position worth an estimated $48.9M. The largest seller was RTW Investments, exiting entirely with an estimated $37.3M sold.

  • 89 institutional investors held Bicycle Therapeutics (BCYC) as of Q1 2023, up from 87 in Q4 2022.
  • Funds reported $499M of Bicycle Therapeutics stock for Q1 2023, down 28% quarter-over-quarter.
  • 18 funds opened new Bicycle Therapeutics positions in Q1 2023 and 15 closed out, a net change of +3 holders.
  • The largest Bicycle Therapeutics buyer in Q1 2023 was Jefferies Financial Group, an estimated $48.9M added.
  • The largest Bicycle Therapeutics seller in Q1 2023 was RTW Investments, an estimated $37.3M sold.

Based on aggregated 13F filings for Q1 2023.